Lawrence Tallon, CEO of the MHRA, discusses the agency's initiatives to advance the UK's regulatory protocols for medical ...

WASHINGTON – Top executives at the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) say they are trying to be pragmatic about their resources and want to learn from other regulatory ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The UK’s drugs regulator is outsourcing almost 40 per cent of applications to trusted regulatory agencies ...

SAN DIEGO — The head of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) said the agency has learned from the challenges that have plagued the implementation of the EU Medical ...

The new hub in Wellington Place will mean better collaboration with other partners in the North, according to the MHRA The UK's drug safety watchdog is to open a new "digital hub" in West Yorkshire.

The regulatory authorities in the UK and US have agreed to work more closely together on the regulation of medical technologies and AI, with the aim of enhancing patient access to new innovations. The ...

Lawrence Tallon has been named as the new Chief Executive Officer of Medicines and Healthcare products Regulatory Agency (MHRA). In response to the announcement, Richard Torbet, Chief Executive of the ...

From left to right: Science Minister Lord Patrick Vallance, Health AI CEO Dr Ricardo Baptista Leite and MHRA CEO Lawrence Tallon. As part of HealthAI’s GRN, the UK’s MHRA will help shape international ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it has become a founding member of a global network of health regulators focused on the safe and effective use of ...